King Oyster, Eryngii · 2007 · Patent
High relevanceENDO-BIOPOLYMERS PRODUCED FROM A SUBMERGED MYCELLIM CULTURE OF PLEUROTUS ERYNGII HAVING ANTITUMOR EFFECTS
Pleurotus eryngii
Key points
- Endo-biopolymers produced from submerged mycelium culture of Pleurotus eryngii are provided to inhibit proliferation of tumor cancer cells, increase activity of natural killer(NK) cells in the spleen and activity of glutathione S-transferase in the liver
- The endo-biopolymers produced from submerged mycelium culture of Pleurotus eryngii, having antitumor activity are provided, wherein the endo-biopolymers are composed of 77.5% of carbohydrates and 21.6% of proteins, and contain glucose and mannoses as major sugars, and glycine and aspartic acid as major amino acids
- An anti-tumor agent contains the endo-biopolymers as effective ingredient
From the paper
Abstract
Endo-biopolymers produced from submerged mycelium culture of Pleurotus eryngii are provided to inhibit proliferation of tumor cancer cells, increase activity of natural killer(NK) cells in the spleen and activity of glutathione S-transferase in the liver. The endo-biopolymers produced from submerged mycelium culture of Pleurotus eryngii, having antitumor activity are provided, wherein the endo-biopolymers are composed of 77.5% of carbohydrates and 21.6% of proteins, and contain glucose and mannoses as major sugars, and glycine and aspartic acid as major amino acids. An anti-tumor agent contains the endo-biopolymers as effective ingredient.
Citation
SONG CHI HYUN, YANG BYUNG KEUN, LIM SANG KYU, JEONG YONG TAE (2007). ENDO-BIOPOLYMERS PRODUCED FROM A SUBMERGED MYCELLIM CULTURE OF PLEUROTUS ERYNGII HAVING ANTITUMOR EFFECTS.
Open citation